These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2787958)

  • 41. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
    Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
    N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States.
    Lip GY; Pan X; Kamble S; Kawabata H; Mardekian J; Masseria C; Bruno A; Phatak H
    Int J Clin Pract; 2016 Sep; 70(9):752-63. PubMed ID: 27550177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Humphries KH; Tu JV; Behlouli H; Guo H; Pilote L
    Circulation; 2014 Mar; 129(11):1196-203. PubMed ID: 24452752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients.
    Hurlen M; Erikssen J; Smith P; Arnesen H; Rollag A
    J Intern Med; 1994 Sep; 236(3):299-304. PubMed ID: 8077887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastrointestinal bleeding risk of non-vitamin K oral anticoagulants is similar to warfarin - a Japanese retrospective cohort study
.
    Shirai T; Yamamoto T; Kawasugi K; Kuyama Y; Kita H
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):841-846. PubMed ID: 27569738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial.
    Beyth RJ; Quinn L; Landefeld CS
    Ann Intern Med; 2000 Nov; 133(9):687-95. PubMed ID: 11074901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function.
    Hirai T; Hamada Y; Geka Y; Kuwana S; Hirai K; Ishibashi M; Fukaya Y; Kimura T
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1491-1497. PubMed ID: 28795244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.
    Larsen TB; Gorst-Rasmussen A; Rasmussen LH; Skjøth F; Rosenzweig M; Lip GY
    Am J Med; 2014 Jul; 127(7):650-656.e5. PubMed ID: 24530792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin.
    Gasse C; Hollowell J; Meier CR; Haefeli WE
    Thromb Haemost; 2005 Sep; 94(3):537-43. PubMed ID: 16268469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation.
    Seeger JD; Bykov K; Bartels DB; Huybrechts K; Zint K; Schneeweiss S
    Thromb Haemost; 2015 Nov; 114(6):1277-89. PubMed ID: 26446507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.
    González-Pérez A; Sáez ME; Johansson S; Himmelmann A; García Rodríguez LA
    BMC Cardiovasc Disord; 2016 Aug; 16(1):164. PubMed ID: 27577589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Warfarin Use and Increased Mortality in End-Stage Renal Disease.
    Lin MC; Streja E; Soohoo M; Hanna M; Savoj J; Kalantar-Zadeh K; Lau WL
    Am J Nephrol; 2017; 46(4):249-256. PubMed ID: 28910806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom.
    Hollowell J; Ruigómez A; Johansson S; Wallander MA; García-Rodríguez LA
    Br J Gen Pract; 2003 Apr; 53(489):312-4. PubMed ID: 12879832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
    Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
    Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive ability of scores for bleeding risk in heart disease outpatients on warfarin in Brazil.
    Oliveira JAQ; Pinho Ribeiro AL; Ribeiro DD; Nobre V; Rocha MODC; Martins MAP
    PLoS One; 2018; 13(10):e0205970. PubMed ID: 30339702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.
    Guo Y; Wang H; Tian Y; Wang Y; Lip GYH
    Chest; 2015 Jul; 148(1):62-72. PubMed ID: 25501045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.